BET bromodomain inhibitor JQ1 effect on MYC-amplified medulloblastoma cell lines
Summary:
Analysis of 5 MYC-amplified medulloblastoma cell lines treated with the BET bromodomain inhibitor JQ1. Cell lines derived from medulloblastoma patients. Results provide insight into the potential use of BET bromodomain inhibitors in the treatment of MYC-amplified medulloblastomas.
GPL6244:
[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]
Citation:
Bandopadhayay P, Bergthold G, Nguyen B, Schubert S et al. BET bromodomain inhibition of MYC-amplified medulloblastoma. Clin Cancer Res 2014 Feb 15;20(4):912-25. PMID: 24297863
